These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 8542394

  • 21. Generation of high-titer defective HSV-1 vectors.
    Lim F, Neve RL.
    Curr Protoc Neurosci; 2001 May; Chapter 4():Unit 4.13. PubMed ID: 18428477
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Gene delivery using herpes simplex virus vectors.
    Burton EA, Fink DJ, Glorioso JC.
    DNA Cell Biol; 2002 Dec; 21(12):915-36. PubMed ID: 12573050
    [Abstract] [Full Text] [Related]

  • 24. Optimal purification method for Herpes-based viral vectors that confers minimal cytotoxicity for systemic route of vector administration.
    Sia KC, Wang GY, Ho IA, Khor HY, Miao L, Hui KM, Lam PY.
    J Virol Methods; 2007 Feb; 139(2):166-74. PubMed ID: 17074404
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Helper virus-free herpes simplex virus-1 plasmid vectors for gene therapy of Parkinson's disease and other neurological disorders.
    Geller AI, Yu L, Wang Y, Fraefel C.
    Exp Neurol; 1997 Mar; 144(1):98-102. PubMed ID: 9126158
    [Abstract] [Full Text] [Related]

  • 29. Oncolytic virotherapy with an HSV amplicon vector expressing granulocyte-macrophage colony-stimulating factor using the replication-competent HSV type 1 mutant HF10 as a helper virus.
    Kohno SI, Luo C, Nawa A, Fujimoto Y, Watanabe D, Goshima F, Tsurumi T, Nishiyama Y.
    Cancer Gene Ther; 2007 Nov; 14(11):918-26. PubMed ID: 17693992
    [Abstract] [Full Text] [Related]

  • 30. Gene delivery using helper virus-free HSV-1 amplicon vectors.
    Fraefel C.
    Curr Protoc Hum Genet; 2002 Aug; Chapter 12():Unit 12.12. PubMed ID: 18428323
    [Abstract] [Full Text] [Related]

  • 31. Genetic engineering of herpes simplex virus and vector genomes carrying loxP sites in cells expressing Cre recombinase.
    Logvinoff C, Epstein AL.
    Virology; 2000 Feb 01; 267(1):102-10. PubMed ID: 10648187
    [Abstract] [Full Text] [Related]

  • 32. In situ cancer vaccination: an IL-12 defective vector/replication-competent herpes simplex virus combination induces local and systemic antitumor activity.
    Toda M, Martuza RL, Kojima H, Rabkin SD.
    J Immunol; 1998 May 01; 160(9):4457-64. PubMed ID: 9574551
    [Abstract] [Full Text] [Related]

  • 33. Properties of a herpes simplex virus multiple immediate-early gene-deleted recombinant as a vaccine vector.
    Watanabe D, Brockman MA, Ndung'u T, Mathews L, Lucas WT, Murphy CG, Felber BK, Pavlakis GN, Deluca NA, Knipe DM.
    Virology; 2007 Jan 20; 357(2):186-98. PubMed ID: 16996101
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Development of a size-restricted pIX-deleted helper virus for amplification of helper-dependent adenovirus vectors.
    Sargent KL, Ng P, Evelegh C, Graham FL, Parks RJ.
    Gene Ther; 2004 Mar 20; 11(6):504-11. PubMed ID: 14999222
    [Abstract] [Full Text] [Related]

  • 38. Construction and characterization of a replication-defective herpes simplex virus 2 ICP8 mutant strain and its use in immunization studies in a guinea pig model of genital disease.
    Da Costa XJ, Bourne N, Stanberry LR, Knipe DM.
    Virology; 1997 May 26; 232(1):1-12. PubMed ID: 9185583
    [Abstract] [Full Text] [Related]

  • 39. [Expression of foreign genes in adult rats' central nervous system by use of defective herpes simplex virus type 1 vectors].
    Yang T, Wang X, Yan Z, Hou Y.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Dec 26; 11(4):306-10. PubMed ID: 15617234
    [Abstract] [Full Text] [Related]

  • 40. Comparative analyses of transgene delivery and expression in tumors inoculated with a replication-conditional or -defective viral vector.
    Ichikawa T, Chiocca EA.
    Cancer Res; 2001 Jul 15; 61(14):5336-9. PubMed ID: 11454670
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.